Dravet syndrome: A systematic literature review of the illness burden

A Strzelczyk, L Lagae, JM Wilmshurst… - Epilepsia …, 2023 - Wiley Online Library
We performed a systematic literature review and narrative synthesis according to a pre‐
registered protocol (Prospero: CRD42022376561) to identify the evidence associated with …

GABAA receptors in epilepsy: Elucidating phenotypic divergence through functional analysis of genetic variants

NL Absalom, SXN Lin, VWY Liao… - Journal of …, 2023 - Wiley Online Library
Normal brain function requires a tightly regulated balance between excitatory and inhibitory
neurotransmissions. γ‐Aminobutyric acid type A (GABAA) receptors represent the major …

Antiseizure medications in Alzheimer's disease from preclinical to clinical evidence

F Bosco, L Guarnieri, V Rania, E Palma… - International journal of …, 2023 - mdpi.com
Alzheimer's disease (AD) and epilepsy are common neurological disorders in the elderly. A
bi-directional link between these neurological diseases has been reported, with patients …

[HTML][HTML] Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (< 5 years) with Dravet syndrome: a critical …

KI Bishop, PK Isquith, GA Gioia, KG Knupp… - Epilepsy & Behavior, 2023 - Elsevier
Objective To evaluate whether fenfluramine (FFA) is associated with improvement in
everyday executive function (EF)—self-regulation—in preschool-aged children with Dravet …

Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis

H Chu, X Zhang, J Shi, Z Zhou, X Yang - Journal of Neurology, 2023 - Springer
Objectives To compare the efficacy and safety of antiseizure medications (ASMs), both as
monotherapies and adjunctive therapies, for idiopathic generalized epilepsies (IGEs) and …

Thalamocortical circuits in generalized epilepsy: Pathophysiologic mechanisms and therapeutic targets

BE Lindquist, C Timbie, Y Voskobiynyk, JT Paz - Neurobiology of disease, 2023 - Elsevier
Generalized epilepsy affects 24 million people globally; at least 25% of cases remain
medically refractory. The thalamus, with widespread connections throughout the brain, plays …

Adverse event profiles of antiseizure medications and the impact of coadministration on drug tolerability in adults with epilepsy

LM Willems, M van der Goten, F von Podewils, S Knake… - CNS drugs, 2023 - Springer
Background Antiseizure medication (ASM) as monotherapy or in combination is the
treatment of choice for most patients with epilepsy. Therefore, knowledge about the typical …

[HTML][HTML] Real-world safety of Lacosamide: A pharmacovigilance study based on spontaneous reports in the FDA adverse event reporting system

P Liu, M He, X Xu, Y He, W Yao, B Liu - Seizure: European Journal of …, 2023 - Elsevier
Introduction Lacosamide is licensed for the treatment of focal seizures in both adults and
children, however there is little information available on its adverse reactions. Using the FDA …

Sleep quality, anxiety, symptoms of depression, and caregiver burden among those caring for patients with Dravet syndrome: a prospective multicenter study in …

M Maltseva, S Schubert-Bast, JP Zöllner, T Bast… - Orphanet journal of rare …, 2023 - Springer
Background This study measured sleep quality among caregivers of patients with Dravet
syndrome (DS) and assessed the impacts of mental health problems and caregiver burden …

Levetiracetam attenuates diabetes-associated cognitive impairment and microglia polarization by suppressing neuroinflammation

Y Zhang, L Wang, H Guo, T Han, Y Chang… - Frontiers in …, 2023 - frontiersin.org
Introduction: Cognitive impairment is a common complication and comorbidity of diabetes.
However, the underlying mechanisms of diabetes-associated cognitive dysfunction are …